Revenue by source
Transcatheter Heart Valves$4.49BSurgical Heart Valve Therapy$1.03BCritical Care$0.00Transcatheter Mitral And Tricuspid Therapies$550.60M
| Segment | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Transcatheter Heart Valves | - | - | $552.10M | $707.70M | $943.60M | $1.18B | $1.63B | $2.03B | $2.29B | $2.74B | $2.86B | $3.42B | $3.52B | $3.88B | $4.11B | $4.49B |
| Surgical Heart Valve Therapy | $838.30M | $1.01B | $787.50M | $801.20M | $826.10M | $785.00M | $774.90M | $807.10M | $761.60M | $841.70M | $761.80M | $889.10M | $893.10M | $999.30M | $981.30M | $1.03B |
| Critical Care | $454.10M | $508.30M | $560.00M | $536.60M | $553.20M | $528.40M | $560.30M | $601.00M | $674.50M | $740.20M | $725.40M | $834.90M | $855.00M | $928.10M | - | - |
| Transcatheter Mitral And Tricuspid Therapies | - | - | - | - | - | - | - | - | - | $28.20M | $41.80M | $86.00M | $116.10M | $197.60M | $352.10M | $550.60M |
Revenue by country
UNITED STATES$3.54BEurope$1.52BRest of World$652.30MJAPAN$354.70M
| Segment | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| UNITED STATES | $567.60M | $605.60M | $812.10M | $939.60M | $1.05B | $1.26B | $1.62B | $1.91B | $2.06B | $2.53B | $2.52B | $2.96B | $3.13B | $3.51B | $3.21B | $3.54B |
| Europe | - | $574.00M | $559.70M | $616.50M | $741.40M | $717.30M | $749.00M | $831.00M | $885.10M | $941.20M | $973.60M | $1.19B | $1.17B | $1.33B | $1.32B | $1.52B |
| Rest of World | $879.40M | $215.30M | $233.70M | $245.80M | - | $267.30M | $289.70M | $346.40M | $385.60M | $429.40M | $435.80M | $550.20M | $601.40M | $709.20M | $572.00M | $652.30M |
| JAPAN | - | $283.70M | $294.10M | $243.60M | $270.80M | $246.20M | $309.30M | $350.30M | $396.80M | $444.70M | $460.10M | $528.90M | $473.60M | $452.40M | $339.80M | $354.70M |